Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury

[1]  R. Chung,et al.  Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  G. Ferraioli,et al.  Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection , 2015, Gut.

[3]  M. Ronsoni,et al.  Single‐centre validation of the EASL‐CLIF Consortium definition of acute‐on‐chronic liver failure and CLIF‐SOFA for prediction of mortality in cirrhosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[4]  W. Kim,et al.  Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites , 2015, Gut.

[5]  Young Youn Cho,et al.  CLIF‐SOFA scoring system accurately predicts short‐term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[6]  A. Davenport,et al.  Renal dysfunction in cirrhosis is not just a vasomotor nephropathy , 2014, Kidney international.

[7]  P. Romero,et al.  Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. , 2014, The Journal of clinical investigation.

[8]  R. Maserati,et al.  Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages , 2013, Retrovirology.

[9]  Stephen M. Canham,et al.  Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion , 2013, Nature chemical biology.

[10]  Foreman,et al.  The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. , 2013, JAMA.

[11]  Terry M. Therneau,et al.  Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.

[12]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[13]  Dominique Thabut,et al.  Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. , 2013, Journal of hepatology.

[14]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[15]  M. Mondelli,et al.  Engagement of Siglec-7 Receptor Induces a Pro-Inflammatory Response Selectively in Monocytes , 2012, PloS one.

[16]  F. Wong,et al.  Acute kidney injury in decompensated cirrhosis , 2012, Gut.

[17]  Keiichiro Sakuma,et al.  Colonic Epithelial Cells Express Specific Ligands for Mucosal Macrophage Immunosuppressive Receptors Siglec-7 and -9 , 2012, The Journal of Immunology.

[18]  S. Pillai,et al.  Siglecs and immune regulation. , 2012, Annual review of immunology.

[19]  P. Sun,et al.  Siglecs Facilitate HIV-1 Infection of Macrophages through Adhesion with Viral Sialic Acids , 2011, PloS one.

[20]  A. Varki.  Letter to the Glyco-Forum: Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them , 2011 .

[21]  Maurizio Biselli,et al.  The MELD score in patients awaiting liver transplant: strengths and weaknesses. , 2011, Journal of hepatology.

[22]  M. Kuijf,et al.  Campylobacter jejuni Lipooligosaccharides Modulate Dendritic Cell-Mediated T Cell Polarization in a Sialic Acid Linkage-Dependent Manner , 2011, Infection and Immunity.

[23]  M. Pavesi,et al.  Prognostic importance of the cause of renal failure in patients with cirrhosis. , 2011, Gastroenterology.

[24]  Michael J. Pencina,et al.  Statistical methods for assessment of added usefulness of new biomarkers , 2010, Clinical chemistry and laboratory medicine.

[25]  Y. Yamaguchi,et al.  Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937. , 2010, Glycobiology.

[26]  R. Schrier,et al.  Renal failure in cirrhosis. , 2009, The New England journal of medicine.

[27]  A. Moretta,et al.  The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. , 2009, Blood.

[28]  W. Stremmel,et al.  Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation , 2009, BMC gastroenterology.

[29]  G. Garcia‐Tsao,et al.  Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program , 2009, The American Journal of Gastroenterology.

[30]  James C Paulson,et al.  Siglecs as targets for therapy in immune-cell-mediated disease. , 2009, Trends in pharmacological sciences.

[31]  C. Parikh,et al.  Acute kidney injury in cirrhosis , 2008, Hepatology.

[32]  L. Pulliam,et al.  Sialoadhesin Expressed on IFN-Induced Monocytes Binds HIV-1 and Enhances Infectivity , 2008, PloS one.

[33]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[34]  R. Kannagi.  Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression. , 2007, Chang Gung medical journal.

[35]  Ajit Varki,et al.  Siglecs and their roles in the immune system , 2007, Nature Reviews Immunology.

[36]  Vicente Arroyo,et al.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.

[37]  T. Gonwa,et al.  Hepatorenal syndrome: pathophysiology and management. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[38]  S. Friedman,et al.  Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. , 2006, Journal of Hepatology.

[39]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[40]  H. Nauwynck,et al.  Porcine Arterivirus Infection of Alveolar Macrophages Is Mediated by Sialic Acid on the Virus , 2004, Journal of Virology.

[41]  K. Kumamoto,et al.  Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers , 2004, Cancer Research.

[42]  T. Yamaji,et al.  A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to α2,8-Disialyl and Branched α2,6-Sialyl Residues , 2002, The Journal of Biological Chemistry.

[43]  P. Klenerman,et al.  Identification and Characterization of a Novel Siglec, Siglec-7, Expressed by Human Natural Killer Cells and Monocytes* , 1999, The Journal of Biological Chemistry.

[44]  R. Biassoni,et al.  Identification and Molecular Cloning of P75/Airm1, a Novel Member of the Sialoadhesin Family That Functions as an Inhibitory Receptor in Human Natural Killer Cells , 1999, The Journal of experimental medicine.

[45]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[46]  K. Hajian‐Tilaki,et al.  Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. , 2013, Caspian journal of internal medicine.

[47]  C. Murray,et al.  The state of US health, : burden of diseases, injuries, and risk factors. , 2013 .

[48]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.

[49]  Yeong-Seok Im,et al.  Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List , 2009 .

[50]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[51]  T. Yamaji,et al.  A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9. , 2002, The Journal of biological chemistry.

[52]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .